Boston Trust Walden’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-219,124
Closed -$17.4M 378
2017
Q2
$17.4M Sell
219,124
-41,722
-16% -$3.16M 0.28% 116
2017
Q1
$18.9M Sell
260,846
-23,093
-8% -$1.69M 0.3% 125
2016
Q4
$21.1M Sell
283,939
-6,660
-2% -$489K 0.33% 126
2016
Q3
$22.8M Sell
290,599
-767
-0.3% -$60.3K 0.38% 104
2016
Q2
$21.9M Sell
291,366
-3,492
-1% -$242K 0.37% 98
2016
Q1
$19.6M Sell
294,858
-4,448
-1% -$275K 0.34% 114
2015
Q4
$18.2M Buy
+299,306
New +$17.8M 0.34% 117

Other funds holding NHI

Boston Trust Walden's NHI Position: Q3 2017 in Review

Boston Trust Walden sold out of National Health Investors (NHI) in Q3 2017, closing a stake of 219,124 shares — an estimated $17.4M sold.

Boston Trust Walden first reported a position in NHI in Q4 2015 and held it in 7 quarters. The position peaked at $22.8M in Q3 2016. 206 funds tracked by Wall St. Rank hold NHI as of Q3 2017.

  • Boston Trust Walden reported no remaining National Health Investors position as of Q3 2017 after selling out during the quarter.
  • Boston Trust Walden sold 219,124 National Health Investors shares in Q3 2017, an estimated $17.4M.
  • Boston Trust Walden first reported a position in National Health Investors in Q4 2015 and held it in 7 quarters.
  • Boston Trust Walden's National Health Investors position peaked at $22.8M in Q3 2016.
  • 206 funds tracked by Wall St. Rank held National Health Investors as of Q3 2017.

Based on Boston Trust Walden's 13F filing for Q3 2017, filed 13 Oct 2017.